Mdma molecule:

Image from PubChem

Mdma Clinical Trials

Randomized, Triple-Blind, Phase 2 Pilot Study Comparing 3 Different Doses of MDMA in Conjunction With Manualized Therapy in 24 Veterans, Firefighters and Police Officers With Chronic Posttraumatic Stress Disorder (PTSD)

To see complete record on, please visit this link

Id: NCT01211405

Organisation Name: Multidisciplinary Association for Psychedelic Studies

Overal Status: Completed

Start Date: October 2010

Last Update: July 11, 2022

Lead Sponsor: Multidisciplinary Association for Psychedelic Studies

Brief Summary: This study is designed to provide information on whether therapy ("talk therapy") combined with the drug MDMA is safe and helpful for subjects with posttraumatic stress disorder (PTSD). The study will compare the effects of a low, a medium and a full dose of MDMA on symptoms of PTSD in 24 veterans, firefighters or police officers. MDMA dose will be assigned at random, and the investigators and the subject will not know the dose given. The researchers will also investigate depression symptoms. The researchers believe that the full dose of MDMA will produce a greater reduction in PTSD symptoms than the two lower doses.

  • Posttraumatic Stress Disorder

Total execution time in seconds: 0.38278698921204